Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

537 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The pharmacokinetics of fondaparinux sodium in healthy volunteers.
Donat F, Duret JP, Santoni A, Cariou R, Necciari J, Magnani H, de Greef R. Donat F, et al. Among authors: santoni a. Clin Pharmacokinet. 2002;41 Suppl 2:1-9. doi: 10.2165/00003088-200241002-00001. Clin Pharmacokinet. 2002. PMID: 12383039 Clinical Trial.
Survival analysis of the non-metastatic cohort of the Italian Association for Medical Oncology (AIOM) Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy (GARIBALDI).
Reni M, Milella M, Bergamo F, Di Marco M, Giommoni E, Cardellino GG, Cavanna L, Bonomi M, Zustovich F, Bozzarelli S, Salmaso F, Spada M, Orsi G, Macchini M, Insolda J, Procaccio L, Santoni A, De Simone I, Caldirola L, Galli F, Pinto C. Reni M, et al. Among authors: santoni a. ESMO Open. 2025 Jan 3;10(1):104001. doi: 10.1016/j.esmoop.2024.104001. Online ahead of print. ESMO Open. 2025. PMID: 39754983 Free article.
Management of latent tuberculosis infection (LTBI) in adult patients with newly diagnosed acute leukemia: results of a survey among Italian centers belonging to SEIFEM (Sorveglianza Epidemiologica Infezioni nelle Emopatie) group.
Forghieri F, Bettelli F, Sgromo S, Nadali G, Del Principe MI, Buzzatti E, Farina F, Cesini L, Giordano A, Criscuolo M, Facchinelli D, Piedimonte M, Sartor C, De Marchi R, Delia M, Mosna F, Cudillo L, Tolomelli G, Basilico CM, Cattaneo C, Fracchiolla NS, Lessi F, Finizio O, Zannetti BA, Santoni A, Fazi P, Marchesi F, Venditti A, Candoni A, Luppi M, Busca A, Pagano L. Forghieri F, et al. Among authors: santoni a. Ann Hematol. 2024 Dec;103(12):6045-6050. doi: 10.1007/s00277-024-06047-6. Epub 2024 Oct 28. Ann Hematol. 2024. PMID: 39465392 No abstract available.
Survival analysis of the metastatic cohort of Italian Association of Medical Oncology (AIOM) GARIBALDI survey.
Reni M, Giommoni E, Bergamo F, Cavanna L, Simionato F, Spada M, Di Marco M, Bernardini I, Cordio SS, Latiano T, Spallanzani A, Silvestris N, Cardellino GG, Bonomi M, Milella M, Luchena G, Tamburini E, Macchini M, Orsi G, Modesti M, Procaccio L, Santoni A, De Simone I, Caldirola L, Galli F, Pinto C. Reni M, et al. Among authors: santoni a. Pancreatology. 2024 Nov;24(7):1160-1166. doi: 10.1016/j.pan.2024.10.002. Epub 2024 Oct 3. Pancreatology. 2024. PMID: 39389862 Free article.
Antiviral prophylaxis to prevent herpes simplex virus (HSV) and varicella zoster virus (VZV) reactivation in adult patients with newly diagnosed acute leukemia: results of a survey submitted to Italian centers belonging to SEIFEM (Sorveglianza Epidemiologica Infezioni nelle Emopatie) group.
Forghieri F, Cordella S, Marchesi F, Itri F, Del Principe MI, Cavalieri E, Pasciolla C, Bonanni M, Criscuolo M, Fiorentini A, Guolo F, Buquicchio C, Prezioso L, Delia M, Melillo L, Audisio E, Zannier ME, Cerchione C, Dargenio M, Cattaneo C, Fracchiolla NS, Pezone S, Perruccio K, Santoni A, Candoni A, Vignetti M, Luppi M, Pagano L, Busca A. Forghieri F, et al. Among authors: santoni a. Ann Hematol. 2024 Oct;103(10):4329-4332. doi: 10.1007/s00277-024-05927-1. Epub 2024 Aug 8. Ann Hematol. 2024. PMID: 39115688 No abstract available.
Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial.
Colombo N, Biagioli E, Harano K, Galli F, Hudson E, Antill Y, Choi CH, Rabaglio M, Marmé F, Marth C, Parma G, Fariñas-Madrid L, Nishio S, Allan K, Lee YC, Piovano E, Pardo B, Nakagawa S, McQueen J, Zamagni C, Manso L, Takehara K, Tasca G, Ferrero A, Tognon G, Lissoni AA, Petrella M, Laudani ME, Rulli E, Uggeri S, Barretina Ginesta MP; AtTEnd study group. Colombo N, et al. Lancet Oncol. 2024 Sep;25(9):1135-1146. doi: 10.1016/S1470-2045(24)00334-6. Epub 2024 Aug 2. Lancet Oncol. 2024. PMID: 39102832 Clinical Trial.
537 results